Clinical trials

Filters
Clear filters
1,718 trials
TrialSponsorPhaseStatusPrimary completion
Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of AgeNCT05871970Protara TherapeuticsPhase 2Recruiting2026-12Estimated
Phase 3 Study of Novavax Vaccine(s) as Booster Dose After mRNA VaccinesNCT05875701NovavaxPhase 3Completed2023-11-11Actual
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of UblituximabNCT05877963TGTXPhase 3Recruiting2027-01-21Estimated
HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLPNCT05883748IRONPhase 2, Phase 3Enrolling by invitation2028-06Estimated
ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD)NCT05889273MapLight TherapeuticsPhase 2Active not recruiting2027-11Estimated
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)NCT05892614ATYRPhase 2Recruiting2026-04Estimated
Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD).NCT05893537Cognition TherapeuticsPhase 2Terminated2025-03-04Actual
Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye DiseaseNCT05896670OculisPhase 2Completed2024-03-27Actual
A Novel, Regulated Gene Therapy (NGN-401) Study for Females With Rett SyndromeNCT05898620NGNEPhase 3Active not recruiting2029-12Estimated
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC PatientsNCT05899608Summit TherapeuticsPhase 3Active not recruiting2028-12-31Estimated
Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion SicknessNCT05903924Vanda PharmaceuticalsPhase 3Completed2024-04-06Actual
A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCVNCT05904470AVIRPhase 2Completed2024-12-09Actual
Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-CNCT05905926ArdelyxPhase 3Enrolling by invitation2031-07Estimated
(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular MelanomaNCT05907954IDEAYA BiosciencesPhase 2Active not recruiting2027-04-30Estimated
To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring HemodialysisNCT05908084HUMAPhase 3Active not recruiting2027-06Estimated
Study of ALTO-300 in MDDNCT05922878Alto NeurosciencePhase 2Recruiting2026-12Estimated
Phase 2/3 Heterologous Boosting Study With Different Dose Levels of Monovalent SARS-CoV-2 rS VaccinesNCT05925127NovavaxPhase 2, Phase 3Completed2024-05-21Actual
A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late XerostomiaNCT05926765MeiraGTx, LLCPhase 2Active not recruiting2027-06Estimated
4D-150 in Patients With Diabetic Macular EdemaNCT059305614D Molecular TherapeuticsPhase 2Active not recruiting2029-02-28Estimated
A Study to Determine the Effect of Triheptanoin Compared With Even-Chain MCT on MCEs in Pediatric Patients With LC-FAODNCT05933200RAREPhase 3Active not recruiting2027-08Estimated
Clinical Study to Assess the Efficacy of Once-daily IMM-124E (Travelan®) in a Controlled Human Infection Model.NCT05933525IMRNPhase 2Completed2024-07-01Actual
This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects with Moderate to Severe Atopic Dermatitis (AD).NCT05935085ANABPhase 2Terminated2024-10-16Actual
Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid ArthritisNCT05942911Incannex Healthcare LtdPhase 2Terminated2024-10-28Actual
Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic AtrophyNCT05949593BLTEPhase 3Active not recruiting2027-06-30Estimated
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder CancerNCT05951179Protara TherapeuticsPhase 2Recruiting2031-10Estimated
POC Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Active Intermediate, Posterior, or Pan NIUNCT05953688ALMSPhase 2Terminated2024-08-13Actual
Trial of BDC-1001 +/- Pertuzumab in Subjects With HER2-Positive Metastatic Breast CancerNCT05954143BOLTPhase 2Terminated2024-09-20Actual
A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt DiseaseNCT05956626OcugenPhase 2, Phase 3Active not recruiting2026-09-28Estimated
Refractory Chronic Cough Improvement Via NAL ER (RIVER)NCT05962151Trevi TherapeuticsPhase 2Completed2025-01-06Actual
Long-Term Voclosporin Treatment in Adolescent and Pediatric Subjects With Lupus NephritisNCT05962788AUPHPhase 3Terminated2025-07-04Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.